surfactin peptide has been researched along with Inflammation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Du, P; Gan, P; Gao, Z; Jin, D; Qi, G; Wang, S; Zhao, X | 1 |
Kim, EK; Kim, YH; Lee, SJ; Park, SY; Ryu, EY | 1 |
Chang, ZQ; Hwang, MH; Jeong, KS; Kang, EH; Lim, JH; Park, SC; Rhee, MH; Yun, HI | 1 |
Jung, JK; Jung, SY; Kim, DK; Kim, K; Lee, CH; Lee, DK; Park, JK | 1 |
4 other study(ies) available for surfactin peptide and Inflammation
Article | Year |
---|---|
Bacillus-produced surfactin attenuates chronic inflammation in atherosclerotic lesions of ApoE(-/-) mice.
Topics: Animals; Apolipoproteins E; Bacillus; Immunomodulation; Inflammation; Interleukin-10; Lipopeptides; Mice; Mice, Knockout; Peptides, Cyclic; Plaque, Atherosclerotic; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2016 |
Heme oxygenase-1 signals are involved in preferential inhibition of pro-inflammatory cytokine release by surfactin in cells activated with Porphyromonas gingivalis lipopolysaccharide.
Topics: Active Transport, Cell Nucleus; Cell Line; Cell Nucleus; Cytokines; Enzyme Activation; Enzyme Induction; Extracellular Signal-Regulated MAP Kinases; Heme Oxygenase-1; Humans; Inflammation; Lipopeptides; Lipopolysaccharides; Macrophages; NF-E2-Related Factor 2; NF-kappa B; Peptides, Cyclic; Porphyromonas gingivalis; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; Up-Regulation | 2010 |
Surfactin C inhibits Mycoplasma hyopneumoniae-induced transcription of proinflammatory cytokines and nitric oxide production in murine RAW 264.7 cells.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Cells, Cultured; Inflammation; Lipopeptides; Mice; Mycoplasma hyopneumoniae; Nitric Oxide; Peptides, Cyclic; RNA, Messenger; Transcription, Genetic | 2008 |
Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Bacterial Proteins; Blood Platelets; Blotting, Western; Calcimycin; Cytosol; Edema; Enzyme Inhibitors; Haplorhini; Inflammation; Isoenzymes; Kidney; Lipopeptides; Male; Mice; Pain; Peptides, Cyclic; Phospholipases A; Phospholipases A2; Rats | 1998 |